Geode Capital Management’s CERo Therapeutics CERO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-846
| Closed | -$12.3K | – | 4530 |
|
|
2025
Q1 | $12.3K | Buy |
+846
| New | +$12.3K | ﹤0.01% | 4419 |
|
|
2024
Q4 | – | Sell |
-79
| Closed | -$14.7K | – | 4520 |
|
|
2024
Q3 | $14.7K | Buy |
79
+55
| +229% | +$10.2K | ﹤0.01% | 4432 |
|
|
2024
Q2 | $14.4K | Buy |
24
+19
| +380% | +$11.4K | ﹤0.01% | 4506 |
|
|
2024
Q1 | $32.5K | Hold |
5
| – | – | ﹤0.01% | 4402 |
|
|
2023
Q4 | $117K | Hold |
5
| – | – | ﹤0.01% | 4137 |
|
|
2023
Q3 | $115K | Hold |
5
| – | – | ﹤0.01% | 4200 |
|
|
2023
Q2 | $114K | Hold |
5
| – | – | ﹤0.01% | 4285 |
|
|
2023
Q1 | $113K | Hold |
5
| – | – | ﹤0.01% | 4299 |
|
|
2022
Q4 | $109K | Hold |
5
| – | – | ﹤0.01% | 4367 |
|
|
2022
Q3 | $106K | Buy |
+5
| New | +$106K | ﹤0.01% | 4543 |
|